June 20, 2014
Kyowa Hakko Kirin announced on June 18 that it will initiate in Europe a PI clinical study of KHK6640, an anti-amyloid beta (Aβ) peptide antibody, for the treatment of prodromal /mild/moderate Alzheimer's disease (AD). Its development in Japan has yet...read more